Abstract: A housing for an electronic device includes a ceramic patterned light transmitting portion and a ceramic light resistant portion surrounding the light transmitting portion. A thickness of the light transmitting portion is in a range from 0.2 mm to 1 mm. A thickness of the light resistant portion is at least 0.3 mm thicker than that of the light transmitting portion.

Abstract: Provided herein are methods for the diagnosis, or management of liver diseases, e.g., hepatocellular carcinoma, using profiles of the miRNAs determined from cellular or acellular body fluids.

Abstract: A method, system and computer program product for providing a service to multiple tenants of an application. Responsive to receiving from a client of a tenant a request, a tenant context of the tenant is bound to the request. With respect to an access to an isolation point of the application in the request, the access to the isolation point is redirected to a partition based on the tenant context bound to the request. The partition may be pre-established for the tenant with respect to the application. Hence, it is possible to provide a multi-tenant solution in a convenient, fast, and cost-effective way, and, in turn, to achieve resource sharing to a greater extent and enhance the resource efficiency.

Abstract: A separation device and a method for transmitting voice signal are disclosed. The separation device includes a line interface adapted to provide an interface for connecting to a telecommunication access system which provides public switched telephone network (PSTN) and data services; a data interface adapted to provide an interface connected with customer premises equipment (CPE) and connected with the line interface; a first communication interface adapted to provide an interface connected with a PSTN communication terminal; a second communication interface adapted to provide an interface connected with a foreign exchange station (FXS) interface of the CPE; and a connection switching unit adapted to connect the first communication interface with the line interface or connect the first communication interface with the second communication interface, and to perform switching between the two connections to implement PSTN communication or VoIP communication respectively.

Abstract: Disclosed are methods for identifying early-stage non-small-cell lung cancer (NSCLC) patients who will have an unfavorable prognosis for the recurrence of lung cancer after surgical resection. The methods are based in part on the discovery that chromosomal copy number gains at Chr19, 34.7 Mb-35.6 Mb can be used for prognostic classification. The methods preferably use fluorescence in situ hybridization with fluorescently labeled nucleic acid probes to hybridize to patient samples to quantify the chromosomal copy number of this genetic locus.

Abstract: The present invention relates to the communication field and discloses a communication method and gateway device based on Session Initiation Protocol (SIP) phones. To enable a SIP phone to communicate over the Circuit Switched (CS) domain of a High Speed Packet Access (HSPA) network, the technical solution of the present invention includes: when receiving SIP signaling from a SIP phone, sending an HSPA call command associated with the SIP signaling to an HSPA network device; when receiving an HSPA call command from the HSPA network device, sending SIP signaling associated with the HSPA call command to the SIP phone; when receiving a Real-Time Transport (RTP) packet from the SIP phone, sending Pulse Code Modulation (PCM) data associated with the RTP packet to the HSPA network device; and when receiving PCM data from the HSPA network device, sending an RTP packet associated with the PCM data to the SIP phone. The present invention is applicable to SIP communications.

Abstract: A digital enhanced cordless telecommunications (DECT) base and a DECT terminal are disclosed. The DECT base includes a housing, a central processing unit (CPU), and a DECT module. The DECT base further includes a high-speed packet access (HSPA) interface module, set inside the housing and connected to the CPU, where the CPU is connected to the DECT module and the HSPA interface module is configured to provide an HSPA card with interfaces to implement wireless communications between the base and the network over the HSPA protocol.

Abstract: The present disclosure provides methods for identifying early stage non-small-cell lung cancer (NSCLC) patients who will have an unfavorable prognosis for the recurrence of lung cancer after surgical resection. The methods are based in part on the discovery of chromosomal copy number abnormalities that can be used for prognostic classification. The methods preferably use fluorescence in situ hybridization with fluorescently labeled nucleic acid probes to hybridize to patient samples to quantify the chromosomal copy number of these genetic loci.

Abstract: There are provided methods and systems for precisely controlling the surfactant concentration and character of ferroelectric nanoparticles in a ferroelectric liquid crystal dispersion. In an aspect, the invention provides an efficient FTIR technique to characterize the status and measure the distribution of the surfactant in ferroelectric particle dispersion. This allows for establishing a reproducible fabrication process for ferroelectric nanoparticle liquid crystal dispersions. The methods also maintain the nanoparticles ferroelectricity, which is provided by the addition of surfactant during a comminution process. The invention therefore optimizes both the milling time (to achieve small particle size and narrow size distribution) and surfactant concentration (to maintain the ferroelectricity during milling).

Abstract: The invention provides a liquid crystal (LC) composite, a LC cell, a LC device, and a method thereof. The LC composite comprises (i) a liquid crystal material, and (ii) a copolymer polymerized from LC monomers and non-LC-monomers; and the LC composite is mechanically stressed/sheared. The invention exhibits numerous merits such as high transmittance in visible and IR range, hysteresis free, and a simple fabrication process; and may be utilized in LC device applications such as adaptive optics e.g. beam steering devices and fast tip-tilt wavefront correctors; and general optical applications such as eye wears, compact cameras and compact telescopes.

Abstract: The present invention relates to purinone derivatives which are agonists of the HM74a receptor. Further provided are compositions and methods of using the compounds herein, and their pharmaceutically acceptable salts for the treatment of disease.

Abstract: Provided herein are methods for the diagnosis, prognosis, or management of proliferative hematological disorders and other diseases using profiles of the ubiquitin-proteasome system determined from acellular body fluids or cell-containing samples. Further provided are methods of predicting response to therapy in certain populations of leukemia patients.

Abstract: Provided herein are methods for the diagnosis, prognosis, or management of neoplastic diseases, i.e. cancer, and other diseases using profiles of the ubiquitin-proteasome system determined from acellular body fluids or cell-containing samples. Further provided are methods of predicting response to therapy in certain populations of cancer patients.

Abstract: Provided herein are methods for the diagnosis, prognosis, or management of neoplastic diseases, i.e. cancer, and other diseases using profiles of the ubiquitin-protcasome system determined from acellular body fluids or cell-containing samples. Further provided are methods of predicting response to therapy in certain populations of cancer patients.

Abstract: The invention concerns bifunctional fusion molecules for the treatment of IgE-mediated allergic conditions and Fc?RI-mediated autoimmune conditions. The invention provides a new therapeutic approach for the treatment of both acute and late-phase allergic responses due to ingestion, inhalation, cutaneous and parenteral exposure to allergens, responses including asthma, allergic rhinitis, atopic dermatitis, severe food allergies, chronic urticaria and angioedema, as well as anaphylactic reactions due to exposures such as bee stings or penicillin allergy. In addition, the invention provides for a novel, safer and more efficacious form of allergy vaccination.

Abstract: A method and a system for switching a voice service between different networks as well as a Customer Premises Equipment (CPE) are disclosed herein. The CPE includes: a switching control module, configured to determine the mode of transmitting voice and switch between the fixed network and the mobile network; a terminal service processing module; a wireless service processing module; a wired service processing module; and a central service processing module, configured to: receive the event information sent by the terminal service processing module, or the wireless service processing module, or the wired service processing module; perform operations indicated in the event information; and send event information for controlling one or more of the following modules: the terminal service processing module, the wireless service processing module, and the wired service processing module.

Abstract: This invention is directed to a novel approach for focusing and expressing DNA vaccinates in Antigen Presenting Cells (APCs) mediated through targeting IgE receptors (Fc?Rs) on APC and driving DNA expression through provision of an APC specific regulatory element This vaccine can be used in the prevention or treatment of allergic disease.

Abstract: The present invention relates to purinone derivatives which are agonists of the HM74a receptor. Further provided are compositions and methods of using the compounds herein, and their pharmaceutically acceptable salts for the treatment of disease.

Abstract: The present disclosure relates to telecommunication, and in particular, to a base station Radio Frequency (RF) duplexer, an RF module, and an RF system. A base station RF apparatus provided herein includes: an enclosure, an intermediate RF processing unit, and a duplexer. The enclosure is located on the duplexer; the intermediate RF processing unit is located inside a cavity enclosed by the enclosure and the duplexer, or on the duplexer; a duplexer cavity and a heat dissipation part exist on the surface of the duplexer; the opening of the duplexer cavity is opposite to or against the enclosure; the heat dissipation part is designed to dissipate heat of the intermediate RF processing unit; and the duplexer is integrally molded. The foregoing technical solution requires no external fasteners, reduces the time of production and assembly. In addition, waterproof design and shielding design are not required, and thus improves the reliability.

Abstract: The invention is directed to methods and kits that allow for classification of non-small cell lung carcinoma tumors and cell lines according to genomic profiles, and methods of diagnosing, predicting clinical outcomes, and stratifying patient populations for clinical testing and treatment using the same.